Physical Function Preservation in Chronic Kidney Disease Rehabilitation

Abstract

Physical function impairment is a significant complication in patients with chronic kidney disease (CKD), contributing to morbidity, reduced quality of life, and increased mortality risk. Rehabilitation strategies to preserve and improve physical function in CKD are an evolving domain, with emerging evidence supporting structured interventions tailored to disease stage and patient comorbidity profiles. This article reviews the epidemiology, pathophysiology, risk factors, clinical features, diagnostic approaches, evidence-based management, and recent advances in physical function preservation among CKD patients, with a focus on practical implications for clinicians.

Introduction

Chronic kidney disease is a global health problem affecting approximately 10% of the adult population, with an increasing prevalence due to the aging population and rising incidence of diabetes and hypertension. Physical dysfunction manifesting as muscle wasting, reduced exercise capacity, and frailty is a common but often underappreciated aspect of CKD. Preserving physical function is crucial, as it is strongly linked to independence, cardiovascular outcomes, hospitalization rates, and overall survival. This review synthesizes current knowledge and clinical strategies to optimize physical rehabilitation in CKD, drawing on the latest guideline recommendations and research findings.

Epidemiology / Disease Burden

CKD is associated with a high burden of physical impairment, with studies indicating that up to 60-70% of advanced CKD patients exhibit reduced muscle strength and endurance. Sarcopenia rates are notably higher in CKD cohorts compared to age-matched controls, and physical performance declines as glomerular filtration rate (GFR) decreases. The impact is profound: lower physical function independently predicts hospitalization, falls, and mortality. Moreover, CKD-related physical impairment contributes to increased healthcare utilization and costs, underscoring the importance of early intervention and prevention strategies.

Pathophysiology

The mechanisms underlying physical dysfunction in CKD are multifactorial. Uremic toxin accumulation, chronic inflammation, metabolic acidosis, and hormonal imbalances (including disturbances in vitamin D, parathyroid hormone, and erythropoietin) collectively promote muscle protein breakdown and inhibit synthesis. Additionally, CKD is associated with mitochondrial dysfunction and impaired capillary density in skeletal muscle, leading to reduced oxidative capacity and exercise intolerance. The interplay of malnutrition, anemia, and neuropathy further exacerbates physical decline. Understanding these mechanisms is essential for targeted rehabilitation interventions.

Risk Factors

Several modifiable and non-modifiable risk factors contribute to physical decline in CKD. Advanced age, female sex, and longer duration of CKD increase vulnerability. Comorbidities such as diabetes, cardiovascular disease, and peripheral vascular disease accelerate muscle wasting and functional loss. Other contributing factors include protein-energy wasting, sedentary lifestyle, and polypharmacy. Notably, dialysis-related factors such as inadequate dialysis dose, intradialytic hypotension, and frequent hospitalizations also play a role in the rapid decline of physical performance.

Clinical Features

Physical function impairment in CKD manifests as reduced muscle strength, decreased walking speed, impaired balance, and overall frailty. Patients often report fatigue, difficulty performing activities of daily living, and increased falls. Objective assessment tools such as the 6-minute walk test, handgrip strength, and short physical performance battery (SPPB) are validated measures to quantify functional status and monitor progression over time. Early recognition of subtle declines is vital to initiate timely rehabilitation strategies.

Diagnosis

Diagnosing functional impairment in CKD requires a multidimensional approach. Clinical evaluation should include history-taking focused on physical activity, fatigue, and falls, complemented by standardized physical performance tests. Laboratory evaluation is essential to identify reversible contributors such as anemia, electrolyte disturbances, and vitamin D deficiency. Imaging (e.g., dual-energy X-ray absorptiometry) may be used to assess muscle mass, particularly in research settings. Importantly, periodic reassessment is recommended to track response to interventions and disease progression.

Treatment & Management

Management strategies are centered on individualized exercise prescription, nutritional optimization, and correction of contributing metabolic derangements. Multicomponent exercise programs combining aerobic, resistance, and balance training have demonstrated efficacy in improving muscle strength, endurance, and quality of life in both predialysis and dialysis-dependent CKD populations. Nutritional interventions, particularly protein supplementation tailored to kidney function and comorbidity, are essential adjuncts. Addressing anemia, optimizing vitamin D status, and managing metabolic acidosis further support muscle preservation. A multidisciplinary approach, involving nephrologists, physiotherapists, dietitians, and nursing staff, is integral to successful rehabilitation.

Recent Advances / Emerging Therapies

Recent research has focused on novel rehabilitation modalities, including intradialytic exercise (exercising during hemodialysis sessions), neuromuscular electrical stimulation for non-ambulatory patients, and digital health interventions (e.g., tele-rehabilitation platforms) to increase accessibility and adherence. Pharmacological agents targeting myostatin inhibition and anabolic pathways are under investigation but are not yet incorporated into standard practice. Early evidence also supports individualized, home-based exercise programs to overcome barriers related to transportation and healthcare access. Ongoing clinical trials are further defining optimal exercise intensity, duration, and modality for different CKD stages.

Guideline Recommendations

Recent guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) organization and other nephrology societies advocate for routine assessment of physical function in CKD patients and incorporation of structured physical activity as a standard component of care. Recommendations emphasize individualized exercise prescription based on patient risk profile, close monitoring for adverse events, and integration with nutritional and medical management. Importantly, education and counseling to address patient-reported barriers, such as fear of injury and lack of motivation, are highlighted as key to successful implementation.

Conclusion

Physical function preservation is a cornerstone of comprehensive CKD management, with robust evidence supporting early and sustained rehabilitation efforts to improve patient outcomes. Multidisciplinary, individualized interventions grounded in understanding of underlying pathophysiology and tailored to patient needs are essential. Ongoing research and evolving guidelines continue to refine best practices, promising further advances in the field. Clinicians are encouraged to prioritize physical function assessment and rehabilitation as an integral part of CKD care.